Home/Filings/4/0001235802-15-000034
4//SEC Filing

UROPLASTY INC 4

Accession 0001235802-15-000034

CIK 0000890846operating

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 3:56 PM ET

Size

15.8 KB

Accession

0001235802-15-000034

Insider Transaction Report

Form 4
Period: 2015-03-31
Kill Robert
Director
Transactions
  • Disposition to Issuer

    Common Stock

    2015-03-31431,6680 total(indirect: By Trust)
  • Disposition to Issuer

    Common Stock

    2015-03-3193,3320 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-03-317,0250 total
    Exercise: $3.76Exp: 2019-03-12Common Stock (7,025 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-03-315,4750 total
    Exercise: $4.83Exp: 2018-09-13Common Stock (5,475 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-03-314,9000 total
    Exercise: $5.26Exp: 2017-12-05Common Stock (4,900 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2015-03-31700,0000 total
    Exercise: $2.34Exp: 2020-07-22Common Stock (700,000 underlying)
Footnotes (6)
  • [F1]Disposed of pursuant to merger agreement between issuer and Cogentix Medical, Inc., formerly Vision-Sciences, Inc. ("Cogentix"), in exchange for 313,658 shares of Cogentix common stock on the effective date of the merger.
  • [F2]These shares are subject to restricted stock assumed by Cogentix in the merger and replaced with 67,816 shares of Cogentix stock valued at $4.56 per shares.
  • [F3]This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 3,560 shares of Cogentix stock for $7.24 per share.
  • [F4]This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 3,978 shares of Cogentix stock for $6.65 per share.
  • [F5]This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 5,104 shares of Cogentix stock for $5.18 per share.
  • [F6]This option, which provided for vesting in three almost equal annual installments beginning on July 23, 2014, was assumed by Cogentix in the merger and replaced with an option to purchase 508,633 shares of Cogentix stock for $3.23 per share.

Issuer

UROPLASTY INC

CIK 0000890846

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000890846

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 3:56 PM ET
Size
15.8 KB